Alkermes plc Target Price

Analysts' average 12-month price target for Alkermes plc is $59.

Get informed when a big investor buys or sells

+ Follow

Share Price

$46.98

Average Target Price

$58.86

25.3% upside

7 analysts in the last 4 months

High: $68 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-11-04	H.C. WainwrightDouglas Tsao	$50	6.4% upside
2026-11-04	Wells FargoBen Burnett	$68	44.7% upside
2026-11-04	Robert W. BairdJoel Beatty	$61	29.8% upside
2026-10-16	Truist Financial	$55	17.1% upside
2026-09-24	Goldman Sachs	$50	6.4% upside
2026-07-28	Piper SandlerDavid Amsellem	$65	38.4% upside
2026-07-20	Stifel NicolausPaul Matteis	$63	34.1% upside
2026-07-02	Mizuho SecuritiesVamil Divan	$65	38.4% upside
2026-06-18	NeedhamAmi Fadia	$54	14.9% upside
2026-06-09	RBC CapitalLeonid Timashev	$56	19.2% upside
2026-05-06	Needham	$50	6.4% upside
2026-02-26	H.C. WainwrightDouglas Tsao	$43	8.5% downside
2026-02-23	Wolfe Research	$45	4.2% downside
2025-10-28	JefferiesAkash Tewari	$56	19.2% upside
2025-10-27	Mizuho Securities	$45	4.2% downside
2025-10-23	Piper SandlerDavid Amsellem	$45	4.2% downside
2025-10-22	RBC Capital	$47	0% upside
2025-09-26	RBC CapitalAlkermes to Outperform	$44	6.3% downside
2025-09-09	Needham	$43	8.5% downside
2025-09-09	H.C. WainwrightDouglas Tsao	$46	2.1% downside
2025-09-02	Wells Fargo	$44	6.3% downside
2025-06-17	UBSAshwani Verma	$42	10.6% downside
2024-12-05	Piper SandlerDavid Amsellem	$37	21.2% downside
2024-11-13	Mizuho SecuritiesVamil Divan	$40	14.9% downside
2024-11-04	Stifel NicolausPaul Matteis	$36	23.4% downside
2024-10-24	Stifel NicolausPaul Matteis	$25	46.8% downside
2024-10-14	H.C. WainwrightDouglas Tsao	$37	21.2% downside
2024-04-10	JefferiesAkash Tewari	$25	46.8% downside
2024-04-09	Mizuho SecuritiesVamil Divan	$35	25.5% downside
2024-04-09	JefferiesAkash Tewari	$25	46.8% downside
2024-03-18	Robert W. BairdJoel Beatty	$37	21.2% downside
2022-12-06	J.P. Morgan	$29	38.3% downside
2022-04-28	Leerink Partners	$27	42.5% downside
2022-04-21	Leerink Partners	$25	46.8% downside
2022-04-20	Goldman Sachs	$35	25.5% downside

Alkermes plc (ALKS) FAQ

Alkermes plc posts a target price of $59. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $59 for ALKS means covering analysts, on average, see the stock 25.3% upside of $46.98 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ALKS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Alkermes plc's other metric pages and overview cover the third.

Judging Alkermes plc against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $59 here, then scan peer and history charts to see if the gap is persistent.